| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
LOC642558 |
FUSIP1, FUSIP2, TASR: FUS-interacting serine-arginine-rich protein 1 |
3.882 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
MARK2 |
IPI00718858 |
3.882 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
IRS2 |
IRS2: Insulin receptor substrate 2 |
3.882 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
MNAR |
PELP1, HMX3, MNAR: Proline-, glutamic acid- and leucine-rich protein 1 |
3.882 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
RNPS1 |
RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 |
3.882 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
BID |
BID: BH3-interacting domain death agonist |
3.882 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
SNCA |
SNCA, NACP, PARK1: Alpha-synuclein |
3.882 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
RAB4A |
IPI00549945 |
3.882 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
AR |
AR, DHTR, NR3C4: Androgen receptor |
3.882 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
NFIA |
NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A |
3.882 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
PPP1R12C |
PPP1R12C, MBS85: Protein phosphatase 1 regulatory subunit 12C |
3.882 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
ATXN2L |
IPI00456363 |
3.882 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
RAVER1 |
RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 |
3.882 |
Evidence |
|
| ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
3.882 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
PTBP1 |
PTBP1: Polypyrimidine tract binding protein 1 |
3.882 |
Evidence |
|
| NFYA |
NFYA: Nuclear transcription factor Y subunit alpha |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
3.882 |
Evidence |
|
| ZP3 |
ZP3, ZP3A, ZP3B, ZPC: Zona pellucida sperm-binding protein 3 precursor |
GRIK2 |
GRIK2, GLUR6: Glutamate receptor, ionotropic kainate 2 precursor |
3.882 |
Evidence |
|
| ZP3 |
ZP3, ZP3A, ZP3B, ZPC: Zona pellucida sperm-binding protein 3 precursor |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
3.882 |
Evidence |
|
| ZP3 |
ZP3, ZP3A, ZP3B, ZPC: Zona pellucida sperm-binding protein 3 precursor |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
3.882 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
ZFP91 |
ZFP91, FKSG11: Zinc finger protein 91 homolog |
3.882 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
BID |
BID: BH3-interacting domain death agonist |
3.882 |
Evidence |
|
| LIG1 |
LIG1: DNA ligase 1 |
SYTL4 |
Endocrine transmitter regulatory protein |
3.882 |
Evidence |
|
| LIG1 |
LIG1: DNA ligase 1 |
ATXN2L |
ATXN2L, A2D, A2LG, A2LP, A2RP: Ataxin-2-like protein |
3.882 |
Evidence |
|
| PTPRA |
IPI00163420 |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
3.882 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
UACA |
UACA, KIAA1561: Uveal autoantigen with coiled-coil domains and ankyrin repeats |
3.882 |
Evidence |
|